Source: Virtual Congress 2021 – Interstitial lung disease around the world



Rating:

Share or cite this content

Citations should be made in the following way:
M. Watson (Cambridge, United Kingdom), T. McLellan (Cambridge, United Kingdom), M. Thillai (Cambridge, United Kingdom). All-cause mortality in an Idiopathic Pulmonary Fibrosis (IPF) cohort: retrospective analysis with cardiac QRISK-2. 3747

Member's Comments

No comment yet.

Related content which might interest you: Idiopathic pulmonary fibrosis (IPF) patients in Poland – preliminary cohort analysis of EMPIRE registry Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Body composition and mortality in idiopathic pulmonary fibrosis (IPF): a prospective cohort study. Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018 Prevalence of cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Effect of pirfenidone on treatment-emergent (TE) all-cause mortality (ACM) in patients with idiopathic pulmonary fibrosis (IPF): Pooled data analysis from ASCEND and CAPACITY Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry Source: Eur Respir J , 49 (2) 1601592; DOI: 10.1183/13993003.01592-2016 Year: 2017 Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Europe. Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis Year: 2021 Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001–2013 Source: Eur Respir J, 51 (1) 1701603; 10.1183/13993003.01603-2017 Year: 2018 Idiopathic Pulmonary Fibrosis: mortality trends in Chile Source: International Congress 2019 – Interstitial lung disease registries Year: 2019 The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol Source: Eur Respir J 2013; 41: 1017-1022 Year: 2013 Idiopathic pulmonary fibrosis: Gender differences in survival and functional decline. A retrospective study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review Source: Eur Respir J 2015; 46: 795-806 Year: 2015 Management-related costs of Idiopathic Pulmonary Fibrosis (IPF) in Belgium Source: Virtual Congress 2020 – How do different treatment strategies translate into costs Year: 2020 Patterns of pulmonary hypertension in Egyptian patients with COPD: A retrospective analysis Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: Analysis of Medicare data Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017 Predictors of mortality in otherwise healthy patients with pulmonary tuberculosis: A retrospective cohort study Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 The burden of Idiopathic Pulmonary Fibrosis (IPF): a multimodal study of prevalence, healthcare utilization and survival Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 Late Breaking Abstract - Frequency Pulmonary embolism (PE) in patients with an acute Exacerbation of chronic obstructive Pulmonary disease (COPD). PEP prospective trial. Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment Year: 2019 Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020